Budesonide Aerosol, Foam
Product Images NDC 68682-658

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 68682-658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Image 01)

Budesonide Rectal Foam 2 mg/actuation aerosol foam for rectal administration by Oceanside Pharmaceuticals. The packaging displays the product name, strength, dosage form, NDC 68682-658-03, and manufacturer details. Each canister contains 14 metered doses with a net weight of 33.4 g. The label includes storage instructions, flammability warnings, and graphics illustrating usage directions.*

FDA Label Image

Formula (Image 02)

Chemical structure of budesonide, a corticosteroid active ingredient. The structural diagram shows the characteristic fused ring steroid backbone with functional groups including hydroxyl groups, a ketone, and an acetal moiety.*

FDA Label Image

Figurea (Image 03)

An instructional diagram showing the components and packaging of budesonide 2 mg/1 aerosol foam rectal applicators. The image includes a box containing four trays, each holding multiple single-use applicators, along with disposal bags. A close-up labels parts of the applicator device, including the dome, safety tab, canister, nozzle, and applicator. The labeler is Oceanside Pharmaceuticals.*

FDA Label Image

Figureb (Image 04)

An instructional illustration showing a close-up view of a round aerosol foam applicator tip with a directed blue arrow pointing right, indicating the direction of foam release from the nozzle.*

FDA Label Image

Figurec (Image 05)

Illustration showing the assembly of a rectal aerosol foam device, with a nozzle or applicator being inserted onto the aerosol canister as indicated by a right-pointing blue arrow.*

FDA Label Image

Figured (Image 06)

An instructional diagram showing the top part of an aerosol foam container with an arrow indicating a circular rotation to open or close the cap. A semicircular notch detail is highlighted on the side where the nozzle attaches, guiding the user on proper alignment or unlocking mechanism.*

FDA Label Image

Figuree (Image 07)

Instructional illustration showing a hand holding and shaking a rectal aerosol foam canister. A stopwatch icon is displayed with the text '10 to 15 SECONDS,' indicating the shaking duration before use. This relates to budesonide 2 mg/1 aerosol foam for rectal administration by Oceanside Pharmaceuticals.*

FDA Label Image

Figuref (Image 08)

An instructional illustration showing a hand holding a rectal aerosol foam applicator. The image demonstrates correct grip and positioning of the applicator for rectal administration of budesonide foam.*

FDA Label Image

Figureg (Image 09)

Illustration showing the rectal administration of an aerosol foam medication using an applicator. The image highlights the insertion angle and positioning of the applicator into the rectal area for budesonide 2 mg/1 aerosol foam by Oceanside Pharmaceuticals.*

FDA Label Image

Figureh (Image 10)

An instructional illustration showing a hand pressing an applicator against a body area with an arrow indicating direction, accompanied by a stopwatch icon and text indicating to press only once and hold for 2 seconds. The image is related to the use of a budesonide rectal aerosol foam.*

FDA Label Image

Figurei (Image 11)

An instructional illustration showing how to spray an aerosol foam rectally, with a timer indicating to wait 10 to 15 seconds after application. The image depicts a hand applying the aerosol foam to the rectal area with an arrow showing the direction of spraying.*

FDA Label Image

Figurej (Image 12)

Illustration showing a hand inserting an aerosol foam applicator into the rectum, indicating the proper administration technique for budesonide aerosol foam, rectal use.*

FDA Label Image

Figurek (Image 13)

An instructional illustration depicting a foil pouch being opened by inserting and pulling out a dropper or nozzle. The image is simple and uses black and gray tones with a red border around the illustration.*

FDA Label Image

Figurel (Image 14)

An instructional illustration showing how to operate the actuator of a rectal aerosol foam canister. It depicts a hand turning the top cap with an arrow indicating the direction to turn for usage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.